DocGo Inc. ( DCGO ) Q3 2025 Earnings Call November 10, 2025 5:00 PM EST Company Participants Mike Cole - Vice President of Investor Relations Lee Bienstock - CEO & Director Norman Rosenberg - Treasurer & CFO Conference Call Participants Philip Chickering Sarah James - Cantor Fitzgerald & Co., Research Division Ryan MacDonald - Needham & Company, LLC, Research Division Jenny Shen - BTIG, LLC, Research Division Aditya Dagaonkar Presentation Operator Good afternoon, ladies and gentlemen, and welcome to the DocGo Third Quarter Earnings Conference Call. [Operator Instructions] This call is being recorded on Monday, November 10, 2025.
DocGo Inc. (DCGO) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to earnings of $0.05 per share a year ago.
DocGo Inc. (NASDAQ:DCGO ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Lee Bienstock - CEO & Director Mike Cole - Vice President of Investor Relations Norman Rosenberg - Treasurer & CFO Conference Call Participants Aditya Dagaonkar - Unidentified Company Operator Good afternoon, ladies and gentlemen, and welcome to the DocGo Second Quarter Earnings Conference Call. [Operator Instructions] This call is being recorded on Thursday, August 7, 2025.
DocGo Inc. (DCGO) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to earnings of $0.06 per share a year ago.
DocGo, Inc (NASDAQ:DCGO ) Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Mike Cole - VP, IR Lee Bienstock - CEO Norman Rosenberg - CFO Conference Call Participants Ryan MacDonald - Needham Kieran Ryan - Deutsche Bank Jenny Shen - BTIG Operator Good afternoon, ladies and gentlemen, and welcome to the DocGo First Quarter Earnings Conference Call. At this time, all lines are in listen-only mode.
DocGo Inc. (DCGO) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to earnings of $0.09 per share a year ago.
DocGo's shares have plummeted over 45% since mid-February, declining over 20% after reporting Q4 '24 on February 27th. The company has relied on contingencies such as COVID-19 testing and large contracts for a significant part of its revenues, much of which has now dried up. The company is transitioning to a new revenue model targeting Health Insurance Partnerships, aiming for more stable and predictable revenues. Yet, this space is highly competitive.
Motion Acquisition (DCGO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
DocGo, Inc (NASDAQ:DCGO ) Q4 2024 Results Conference Call February 27, 2025 5:00 PM ET Company Participants Mike Cole - VP of Investor Relations Lee Bienstock - Chief Executive Officer Norman Rosenberg - Chief Financial Officer Conference Call Participants Pito Chickering - Deutsche Bank Richard Close - Canaccord Genuity David Larsen - BTIG Aidan Conniff - Stifel Operator Good afternoon, ladies and gentlemen, and welcome to the DocGo Fourth Quarter and Full Year 2024 Earnings Call. At this time, all lines are in listen only mode.
DocGo Inc. (DCGO) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.06 per share a year ago.
DocGo (DCGO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
DocGo, Inc. (NASDAQ:DCGO ) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Michael Cole - VP, IR Lee Bienstock - CEO Norman Rosenberg - CFO Conference Call Participants Pito Chickering - Deutsche Bank Ryan MacDonald - Needham Operator Welcome to DocGo, Inc. Third Quarter 2024 Earnings Call. [Operator Instructions].